Furoscix Injection
Product Images NDC 71767-111

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Furoscix (NDC 71767-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Scpharmaceuticals Inc., A Wholly Owned Subsidiary Of Mannkind Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Physician Sample (Combination Product Physician Sample)

FUROSCIX furosemide injection 80 mg/10 mL (8 mg/mL) subcutaneous injection carton by scPharmaceuticals Inc., a MannKind Corporation subsidiary. The label shows a single-dose prefilled cartridge, on-body infusor device image, and package contents including alcohol prep pads and instructions. Marked Rx only and physician sample not for sale.*

FDA Label Image

Combination Product Primary Carton (Combination Product Primary Carton)

Packaging label for FUROSCIX (furosemide injection) 80 mg/10 mL (8 mg/mL) subcutaneous injection. The label displays the brand name, strength, and dosage form, along with an image of the on-body infusor device and prefilled cartridge. The label indicates this is a prescription drug by scPharmaceuticals Inc., a subsidiary of MannKind Corporation, and includes contents such as alcohol prep pads and instructions for use.*

FDA Label Image

Tyvek Lid (Device Tyvek Lid)

Label for FUROSCIX furosemide injection, 80 mg/10 mL (8 mg/mL) for subcutaneous use. The label indicates it is an on-body infusor. It includes manufacturer information for scPharmaceuticals Inc., listing an address in Burlington, MA, USA, and a contact phone number. Various symbols indicate storage temperatures, sterility, and handling instructions, along with the NDC 71767-100 and reference number 1955 9012.*

FDA Label Image

Device Pad (Device)

On-body infusor device for FUROSCIX (furosemide injection) 80 mg/10 mL (8 mg/mL) subcutaneous injection. The white device features a central blue button with labeling including the product name, strength, and contact information for scPharmaceuticals Inc.*

FDA Label Image

Cartridge Carton (Drug Product Cartridge Carton)

FUROSCIX furosemide injection 80 mg/10 mL (8 mg/mL) carton panel for subcutaneous injection by scPharmaceuticals Inc. The label includes dosage strength, route, manufacturer contact, storage conditions, inactive ingredients, barcode, lot and expiration placeholders, and a caution to protect from light. It specifies single-dose use and provides the website www.furoscix.com.*

FDA Label Image

Cartridge (Drug Product Cartridge)

Label for FUROSCIX (furosemide injection) showing strength of 80 mg/10 mL (8 mg/mL) in a 10 mL single dose cartridge. The label indicates subcutaneous use only, storage temperature 20°C to 25°C, and manufacturer as scPharmaceuticals Inc. The label includes a barcode and space for lot and expiration date.*

FDA Label Image

Figure A (Figure A)

An instructional diagram showing parts of an On-Body Infusor device with a Prefilled Cartridge. Labels identify the White Tab (Adhesive Liner), Blue Tab (Adhesive Backing), Indicator Light, Start Button on the infusor, and cartridge components including Tip, Cartridge Window, and Cartridge Holder.*

FDA Label Image

Figure B (Figure B)

An illustration showing a small cabinet with an open door revealing two shelves inside, with a rectangular object on the upper shelf. The image is labeled as Figure B.*

FDA Label Image

C (Figure C)

An instructional illustration showing hands being washed under a running stream of water from a faucet. The image emphasizes hand hygiene, likely related to preparation or administration steps for medication.*

FDA Label Image

D (Figure D)

An instructional diagram labeled Figure D, showing a hand pointing to an expiration date location on a product packaging. The expiration date format is indicated as YYYYMMDD.*

FDA Label Image

E (Figure E)

An instructional diagram labeled Figure E showing the contents of a FUROSCIX injection kit. The illustration includes a prefilled injection cartridge, two alcohol prep pads, a device label, and a handheld injector device arranged above an open box, with arrows indicating these items are to be taken from the box.*

FDA Label Image

F (Figure F)

Instructional illustration showing the FUROSCIX on-body infusion system for furosemide 80 mg/mL subcutaneous injection. The image includes the on-body infusor device, prefilled cartridge, alcohol wipes, a trimming tool, and a sharps container, accompanied by usage instructions and labeled parts for assembly and operation guidance.*

FDA Label Image

G (Figure G)

An instructional illustration showing a hand holding a subcutaneous injection device labeled with the strength 80 mg/mL. The image includes an arrow pointing from the device to a person's eye, demonstrating the proper orientation or inspection step before administration.*

FDA Label Image

H (Figure H)

Instructional illustration showing a hand holding a vial or cartridge upright with a small opening at the bottom, accompanied by an arrow pointing towards an eye, indicating a step related to visual inspection or attention during preparation or administration.*

FDA Label Image

I (Figure I)

Illustration showing the proper way to remove the tip (small end) from a medical injection device, demonstrating hand positioning for correct usage.*

FDA Label Image

J (Figure J)

An instructional illustration labeled Figure J showing hands operating a medical device for subcutaneous injection. The image depicts pressing a blue button on the device, accompanied by a 'Beep' sound indicator, and pulling a part outward to possibly prepare or activate the device.*

FDA Label Image

K (Figure K)

An instructional illustration showing how to insert a cartridge into a cartridge holder. The cartridge tip is pointed downward inside the holder, with one hand holding the device open and the other hand placing the cartridge. The text beside the image reads 'Cartridge Tip Pointing Down Inside Cartridge Holder Figure K.'*

FDA Label Image

L (Figure L)

An instructional illustration showing hands pressing a button on a FUROSCIX drug delivery device, with an arrow indicating the direction of the press and a blue light indicating activation or status. The figure is labeled 'Figure L.'*

FDA Label Image

M (Figure M)

Illustration showing the front torso of a male, focusing on the lower abdomen with two green highlighted areas suggesting the anatomical regions relevant for subcutaneous injection or drug administration.*

FDA Label Image

N (Figure N)

Illustration showing a hand holding a razor, shaving an area of the skin. This image likely depicts preparation of a site for subcutaneous injection, corresponding with FUROSCIX (furosemide) injection administration instructions.*

FDA Label Image

O (Figure O)

Illustration showing a hand wiping a person's abdominal area with a cloth or wipe, likely demonstrating a preparation step for subcutaneous injection administration.*

FDA Label Image

P (Figure P)

Illustration showing hands peeling back a protective seal or cover from a medical device or package, indicated by an upward arrow. The image appears to be part of instructional material related to FUROSCIX injection preparation or use.*

FDA Label Image

Q (Figure Q)

An instructional illustration showing hands holding a FUROSCIX injection device against a person's abdominal area, demonstrating the proper placement or application for subcutaneous injection of furosemide.*

FDA Label Image

R (Figure R)

An instructional diagram showing hands pressing a FUROSCIX subcutaneous injection device firmly onto the skin. The image highlights proper placement and pressure application for device activation, featuring bold text instructing to "Press Firmly Onto the Skin."*

FDA Label Image

S (Figure S)

An instructional illustration showing a hand pressing and releasing a device attached to the skin for subcutaneous administration. The zoomed inset highlights a green light indicator flashing with a 'Beep Beep Beep' sound signal, indicating operation status.*

FDA Label Image

T (Figure T)

Illustration showing a subcutaneous injection device applied to the skin with a clock indicating a 5-hour timeframe. The image likely demonstrates usage or timing for the injection of FUROSCIX (furosemide) subcutaneous injection.*

FDA Label Image

U (Figure U)

An instructional diagram showing a subcutaneous injection device with a visible white plunger. The diagram highlights the position of the white plunger with a green check mark, indicating correct placement. The image also includes a sound icon with "Beep" depicted three times, suggesting the device emits beeping sounds during use.*

FDA Label Image

V (Figure V)

An illustration showing the application of a FUROSCIX subcutaneous injection device on the skin. A hand is pulling back a blue adhesive tab from the device, which is positioned on the patient's abdomen near the navel area.*

FDA Label Image

W (Figure W)

Illustration showing a hand disposing of a used injection device into a red sharps container labeled with a warning symbol and the text 'Sharps Container.' This image depicts safe disposal procedures for injection equipment.*

FDA Label Image

X (Figure X)

An instructional illustration showing a FUROSCIX injection device with a close-up view highlighting a red alert light on the device. The diagram includes sound cues indicated by 'Beep' to signify an alert or status notification on the injection device.*

FDA Label Image

Structure (Furosemide Structure)

Chemical structure of furosemide, displaying its molecular configuration with labeled functional groups including a sulfonamide, carboxylic acid, chlorine-substituted aromatic ring, and a furan ring.*

FDA Label Image

Symb (Ifu Symbols)

A symbols legend table explaining various packaging and usage symbols, including instructions to read the instructions before use, expiration date, temperature limitation, prescription-only notice, catalog number, serial number, lot number, sterilization by ethylene oxide, a keep dry symbol, single-use only, non-pyrogenic, manufactured for, Type BF equipment, do not use if package is opened or damaged, humidity limitation, atmospheric pressure limitation, and MRI unsafe caution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.